Committee for Orphan Medicinal Products (COMP): 11-13 September 2018
Date:
11/09/2018 to 13/09/2018
Location:
European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Minutes of the COMP meeting 11-13 September 2018 (PDF/351.78 KB)
Adopted
First published: 06/12/2018
EMA/COMP/506115/2018 -
List item
Agenda - COMP agenda of the 11-13 September 2018 meeting (PDF/324.15 KB)
Draft
First published: 11/09/2018
EMA/COMP/506115/2018 -
List item
COMP meeting report on the review of applications for orphan designation: September 2018 (PDF/169.43 KB)
First published: 01/10/2018
EMA/COMP/547914/2018